We are live on ! Find out more
RUBY

Rubius Therapeutics, Inc
RUBY

Delisted

RUBY was delisted on the 6th of March, 2023.

Back to rankings
 

About: Rubius Therapeutics Inc develops red cell therapeutics (RCTs) for the treatment of patients with rare diseases, cancer, and autoimmune diseases.

Employees: 6

Healthcare Drug Manufacturers - General

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 0%
Neutral 0%
Negative 0%

We haven’t received any recent news articles for RUBY

See News Rankings
Price charts implemented using Lightweight Charts™